Biohaven

Developer of radiopharmaceuticals for the treatment of neurological and neuropsychiatric diseases

placeNew Haven, Connecticut, United States calendar_todayFounded 2022 groups202 employees language biohaven.com

Registered entities

Social engagement

Social engagement: 58.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

Based on job postings tracked across public sources.

Recent activity

2 Jul 2026
Expansion
office
10 Jun 2026
Event
European Renal Association (ERA) Congress
8 Jun 2026
Event
Goldman Sachs Annual Global Healthcare Conference
Coming soon